Upper GI pharmacology Flashcards
- Describe the possible side effects and drug interactions of PPIs and H2 antagonists.
PPI- hypergastrinemia, cyp 450 inhibitor
H2- gynecomastia, mental status changes in elderly
- Explain the rationale for antibiotic therapy of peptic ulcers.
H. Pylori
- Describe the site and mechanism of action of major prokinetic agents and list their side effects.
diarrhea
- Describe the site and mechanism of action and the relative efficacy of the major antiemetic agents and list their side effects.
drowsiness, constipation,
omeprazole DDI
clopidogrel
cimetidine s/e
gynecomastia, mental status changes, possible tolerance with continued use
Sucralfate
Sulfated disaccharide Al+++ salt binds necrotic tissue forming protective barrier
Activated by acidic pH – give on empty stomach – 2-4 / day
Not absorbed – few side effects – constipation
Diminishing use
Misoprostol
Prostaglandin analog - acts on epithelial cell H+ secretion - mucus-bicarbonate
Indicated for NSAID-induced ulcers
Side effects limit use – diarrhea, uterine cramping, contraindicated in pregnancy
Calcium (as carbonate [Tums])
Rapid, prolonged neutralization rebound secretion
Safe - not for chronic use (but OK as Ca++ supplement)
Constipation - hypercalcemia - renal calculi possible
Magnesium (as hydroxide [Milk of Magnesia])
Osmotic diarrhea – used to counteract Al+++ or Ca++-induced constipation (Maalox - Mylanta)
Avoid if renal disease retention of Mg++ ions
Aluminum (hydroxide [Amphojel], carbonate [Basaljel])
Widely used, binds phosphate in gut (used in CKD)
Main side effect is constipation
Chronic intake may lead to CNS toxicity
drug causes of gastroparesis
Ca2+, opiates, calcium channel blockers
pro kinetics for gastroparesis
Metoclopramide - FDA black box warning
D2 antagonist, 5-HT4 agonist, 5-HT3 antagonist
Domperidone - Canada/Mexico
Doesn’t cross BBB, but cardiac side effects
Anti-emetics-e.g. Compazine (prochlorperazine)
Erythromycin – IV to “kick start”; less effective po with side effects concern
Metoclopramide (Reglan®)
Dopamine antagonist blocks presynaptic inhibition of ACh release
in coordinated contractions enhance transit
Approved for not > 12 weeks
Additional benefit of antiemetic effect at chemoreceptor trigger zone (weak 5HT3 antagonist) relief of n/v
Somnolence, dystonic reactions, tardive dyskinesias [Boxed warning]
Tegaserod (Zelnorm®) - Cisapride (Propulsid®)
5HT4 receptor agonists direct stimulation of ACh release
↑ coordinated contractions-transit in esophagus, stomach
Reduces bloating of irritable bowel syndrome (IBS)
Cisapride life-threatening arrhythmias (↑ QT interval) - restricted
Tegaserod linked to strokes, MI, angina - restricted